BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3030823)

  • 21. MRI accurately depicts underlying DCIS in a patient with Paget's disease of the breast without palpable mass and mammography findings.
    Amano G; Yajima M; Moroboshi Y; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2005 Mar; 35(3):149-53. PubMed ID: 15741305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nipple aspirate fluid cytology in breast carcinoma.
    Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
    Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
    Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N
    Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast carcinoma-in-situ: an emerging problem in Singapore.
    Chua CL; Tan PK; Chiang G; Soo KC; Low CH
    Singapore Med J; 1992 Aug; 33(4):383-5. PubMed ID: 1329232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour-positive sentinel node findings in patients with ductal carcinoma in situ.
    Leidenius M; Salmenkivi K; von Smitten K; Heikkilä P
    J Surg Oncol; 2006 Oct; 94(5):380-4. PubMed ID: 16967467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The problem of ductal carcinoma in situ of the breast.
    Fentiman IS
    Ann Chir Gynaecol; 1992; 81(4):334-6. PubMed ID: 1336650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy.
    Finkelstein SD; Sayegh R; Thompson WR
    Am Surg; 1993 Jul; 59(7):410-4. PubMed ID: 8391769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
    de Mascarel I; MacGrogan G; Mathoulin-Pélissier S; Soubeyran I; Picot V; Coindre JM
    Cancer; 2002 Apr; 94(8):2134-42. PubMed ID: 12001109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lobular neoplasia on core-needle biopsy--clinical significance.
    Arpino G; Allred DC; Mohsin SK; Weiss HL; Conrow D; Elledge RM
    Cancer; 2004 Jul; 101(2):242-50. PubMed ID: 15241819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
    Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
    Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of state-of-the-art mammography in the detection of nonpalpable breast carcinoma.
    Kaplan C; Matallana R; Wallack MK
    Am Surg; 1990 Jan; 56(1):40-2. PubMed ID: 2153010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
    Westenberg AH; Rutgers EJ; Peterse JL; Hendriks JH; Beex LV; van Tienhoven G
    Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2157-61. PubMed ID: 14626831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lobular carcinoma in situ of the breast.
    Goldschmidt RA; Victor TA
    Semin Surg Oncol; 1996; 12(5):314-20. PubMed ID: 8873318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
    Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ductal lavage in patients undergoing mastectomy for mammary carcinoma: a correlative study.
    Brogi E; Robson M; Panageas KS; Casadio C; Ljung BM; Montgomery L
    Cancer; 2003 Nov; 98(10):2170-6. PubMed ID: 14601086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
    Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
    Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.